China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China
· Delayed Price · Currency is CNY 26.06
-0.04 (-0.15%)
Apr 29, 2026, 3:04 PM CST
SHE:000999 Revenue
China Resources Sanjiu Medical & Pharmaceutical had revenue of 8.13B CNY in the quarter ending March 31, 2026, with 18.62% growth. This brings the company's revenue in the last twelve months to 32.88B, up 20.98% year-over-year. In the year 2025, China Resources Sanjiu Medical & Pharmaceutical had annual revenue of 31.60B with 14.43% growth.
Revenue (ttm)
32.88B
Revenue Growth
+20.98%
P/S Ratio
1.32
Revenue / Employee
1.08M
Employees
30,304
Market Cap
43.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 31.60B | 3.99B | 14.43% |
| Dec 31, 2024 | 27.62B | 2.88B | 11.63% |
| Dec 31, 2023 | 24.74B | 6.66B | 36.83% |
| Jan 1, 2023 | 18.08B | 2.54B | 16.31% |
| Jan 1, 2022 | 15.54B | 1.91B | 13.98% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 11.67B |
| Dong-E-E-Jiao | 6.80B |
| Huadong Medicine | 44.06B |
| Shenzhen Salubris Pharmaceuticals | 4.52B |
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| Humanwell Healthcare (Group) | 23.96B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |